Clinical Trials Browser

Active not recruiting × OTHER × Head & Neck × Clear all

NCT06880289 2026-06-05

Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer

Phase 2 Active not recruiting

Squamous Cell Tumors of the Head and Neck

NCT04285476 2026-06-04

PREDICYTHY

Phase NA Active not recruiting

Thyroid Neoplasms

NCT04895735 2026-06-04

MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

Phase 2 Active not recruiting

45 enrolled 12 charts

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms

NCT05784012 2026-06-04

RADIAN

Phase 1/2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT05048459 2026-06-02

Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease

Phase NA Active not recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT05681039 2026-06-02

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT04825990 2026-06-01

POINT

Phase 2 Active not recruiting

Nasopharyngeal Carcinoma

NCT04858269 2026-06-01

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT07556367 2026-06-01

Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients

Phase NA Active not recruiting

Head and Neck Neoplasms

NCT02597738 2026-05-29

A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine

Phase NA Active not recruiting

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT05211232 2026-05-29

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Phase 3 Active not recruiting

Nasopharyngeal Carcinoma

NCT05145660 2026-05-28

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

Phase 3 Active not recruiting

Nasopharyngeal Carcinoma

NCT06308913 2026-05-26

Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma

Phase EARLY_PHASE1 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT01098955 2026-05-22

Smoking Cessation Treatment for Head & Neck Cancer Patients

Phase EARLY_PHASE1 Active not recruiting

Head and Neck Neoplasms, Neoplasms, Smoking Cessation

NCT03449108 2026-05-22

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Phase 2 Active not recruiting

BreastEndocrineGynecologicHead & NeckSarcoma

Bone Neoplasms, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Giant Cell Tumor of Bone, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms, Thyroid Carcinoma, Anaplastic

NCT05119036 2026-05-22

Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma

Phase NA Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT02253238 2026-05-20

Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients

Phase NA Active not recruiting

Dehydration, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms

NCT03491176 2026-05-20

Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer

Active not recruiting

Head and Neck Neoplasms

NCT04759911 2026-05-20

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

Phase 2 Active not recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT06855212 2026-05-20

Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT07600580 2026-05-20

The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Response

Phase 4 Active not recruiting

Goiter, Thyroid Diseases, Thyroid Neoplasms

NCT00593840 2026-05-19

Phase II Trial Evaluating Elimination of Radiation Therapy

Phase 2 Active not recruiting

74 enrolled 10 charts

Laryngeal Neoplasms

NCT05743569 2026-05-19

3D Specimen Maps for RT Planning

Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05787639 2026-05-19

Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)

Phase 2 Active not recruiting

Oropharyngeal Neoplasms

NCT06234748 2026-05-18

ARTHOUSE

Phase 2 Active not recruiting

Oropharyngeal Neoplasms

NCT06904365 2026-05-18

OvAR-Y

Active not recruiting

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Uterine Neoplasms

NCT04848116 2026-05-14

Spark2

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT01704586 2026-05-12

CLERAD-PROBE

Phase NA Active not recruiting

EndocrineHead & Neck

Differentiated Thyroid Carcinoma

NCT07283861 2026-05-12

Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection

Phase NA Active not recruiting

Head and Neck Neoplasms

NCT03930498 2026-05-11

Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma

Phase 2 Active not recruiting

Nasopharyngeal Carcinoma

NCT04373642 2026-05-11

QUADSHOT

Phase 2 Active not recruiting

Head and Neck Neoplasms

NCT05780372 2026-05-11

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Phase 3 Active not recruiting

Nasopharyngeal Carcinoma

NCT04414540 2026-05-08

Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients

Phase 2 Active not recruiting

21 enrolled 12 charts

Squamous Cell Carcinoma of Head and Neck

NCT04502407 2026-05-08

Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer

Phase 2 Active not recruiting

HPV Positive Oropharyngeal Squamous Cell Carcinoma

NCT05074940 2026-05-08

Amivantamab in Adenoid Cystic Carcinoma

Phase 2 Active not recruiting

21 enrolled 13 charts

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms

NCT01398085 2026-05-07

IoN

Phase 2/3 Active not recruiting

EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT02135042 2026-05-07

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Phase 2/3 Active not recruiting

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT04116047 2026-05-07

CompARE

Phase 3 Active not recruiting

Oropharyngeal Neoplasms

NCT05201859 2026-05-07

Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma

Phase 2 Active not recruiting

Nasopharyngeal Carcinoma

NCT05524168 2026-05-07

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Phase 2 Active not recruiting

Nasopharyngeal Carcinoma

NCT04403620 2026-05-06

HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer

Phase 1/2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT05182229 2026-05-06

Comparing Two Ways to Manage Head and Neck Lymphedema

Phase NA Active not recruiting

Head and Neck Neoplasms, Lymphedema

NCT02270814 2026-05-05

CACTUX

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02641093 2026-05-04

Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

Phase 2 Active not recruiting

96 enrolled 12 charts

Head and Neck Neoplasms

NCT05077072 2026-05-04

Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients

Phase 2 Active not recruiting

Head and Neck Carcinoma

NCT02088645 2026-05-01

Lumed

Phase 1 Active not recruiting

EndocrineHead & NeckNET

Thyroid cancer, medullary, Carcinoma, Medullary, Neuroendocrine Tumors

NCT03624751 2026-05-01

Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment

Active not recruiting

Thyroid Neoplasms

NCT05081531 2026-04-30

RadiomicArt

Phase NA Active not recruiting

Head and Neck Neoplasms

NCT05531916 2026-04-30

CIPN

Phase NA Active not recruiting

Nasopharyngeal Carcinoma

NCT02495896 2026-04-29

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Phase 1 Active not recruiting

GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms